PGxPredict™:CLOZAPINE - Providing more informed treatment decisions for patients with schizophrenia
Clozapine is considered by many to be the most effective treatment for refractory schizophrenia on the market today. But it carries a significant risk of agranulocytosis, a rare but life-threatening depletion of white blood cells.
The PGxPredict:CLOZAPINE test makes it possible to provide patients with specific information about their probability of developing agranulocytosis in response to clozapine.
|
